Product Description: Paxalisib (GDC-0084) is a brain penetrant inhibitor of PI3K and mTOR, with Kis of 2 nM, 46 nM, 3 nM, 10 nM and 70 nM for PI3Kα PI3Kβ, PI3Kδ, PI3Kγ and mTOR, respectively[1].
Applications: Cancer-Kinase/protease
Formula: C18H22N8O2
References: [1]Heffron TP, et al. Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR. ACS Med Chem Lett. 2016 Feb 16;7(4):351-6.
CAS Number: 1382979-44-3
Molecular Weight: 382.42
Compound Purity: 99.63
Research Area: Cancer
Solubility: DMSO : 7.69 mg/mL (ultrasonic;warming;heat to 60°C)
Target: mTOR;PI3K